The FDA today updated its safety review of the smoking cessation drug varenicline (Chantix, Pfizer). A large meta-analysis, which the FDA had required Pfizer to perform, found a higher rate of major adverse cardiovascular events (MACE) in patients taking varenicline than in patients taking placebo. However, the increase in risk was very small and did not achieve statistical…
FDA Safety Review Finds Small, Nonsignificant Increased Risk With Chantix (Varenicline)
December 12, 2012 by Leave a Comment
No Surprise: Smoking and Sudden Cardiac Death Closely Tied
December 11, 2012 by 3 Comments
Although cigarette smoking has long been linked to cardiovascular (CV) disease and sudden cardiac death (SCD), the precise contribution of smoking, and the effect of smoking discontinuation, on SCD has not been clear. Now a new report from the Nurses’ Health Study published in Circulation: Arrhythmia & Electrophysiology provides new clarity about the relationship between smoking…
The Research Agrees: Smoking Is Really Bad For You
October 29, 2012 by Leave a Comment
Four new studies offer powerful evidence of the dangers of smoking and the health benefits of quitting or not being exposed to secondhand smoke. Smoking in the UK– Between 1996 amd 2001 the Million Women Study started following more than one million women aged 50 to 65 years of age. In a report published in…
Recent Comments